Duality Biotherapeutics, Inc.(HK:9606)
HK$108.70+0.30 (+0.28%)
HK:9606
Duality Biotherapeutics, Inc. Revenue
HK$108.70
At close:+0.30 (+0.28%)
Want to see HK:9606 full AI Analyst Report?
Duality Biotherapeutics, Inc. (9606) Revenue
5 Followers
Duality Biotherapeutics, Inc. Revenue
Duality Biotherapeutics, Inc. had a revenue of 109.67M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 842.13M, Decreased 37.48%. In the fiscal year ending Dec 31, 2025, Duality Biotherapeutics, Inc. had annual revenue of 1.80B with -7.08% growth.
- Revenue (ttm)
- 842.13M
- Revenue Growth
- ―
- P/S Ratio
- 5.53
- Revenue/Employee
- HKD 7,808,701
- Employees
- 231
- Market Cap
- HKD 9.97B
Revenue Chart
Duality Biotherapeutics, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.80B | -137.45M | -7.08% |
| Dec 31, 2024 | 1.94B | 154.72M | 8.66% |
| Dec 31, 2023 | 1.79B | 1.78B | 111558.75% |
| Dec 31, 2022 | 1.60M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.